BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1515448)

  • 1. Accelerated graft coronary artery disease: diagnosis and prevention.
    Schroeder JS; Gao SZ; Hunt SA; Stinson EB
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S258-65. PubMed ID: 1515448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium blockers and atherosclerosis: lessons from the Stanford Transplant Coronary Artery Disease/Diltiazem Trial.
    Schroeder JS; Gao SZ
    Can J Cardiol; 1995 Sep; 11(8):710-5. PubMed ID: 7671182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
    Kocík M; Málek I; Janek B; Zelízko M; Pirk J
    Transpl Int; 2007 Aug; 20(8):666-74. PubMed ID: 17521382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary disease in patient following heart transplantation].
    Benvenuti C; Nitenberg A; Aptecar E; Tavolaro O; Deleuze P; Castaigne A; Loisance D; Cachera JP
    Arch Mal Coeur Vaiss; 1991 Feb; 84(2):213-8. PubMed ID: 1850586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings].
    Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M
    Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis.
    Gao SZ; Schroeder JS; Hunt SA; Valantine HA; Hill IR; Stinson EB
    J Heart Lung Transplant; 1993; 12(6 Pt 1):1029-35. PubMed ID: 8312304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual forms of ischemic heart disease.
    Drexler H; Schroeder JS
    Curr Opin Cardiol; 1994 Jul; 9(4):457-64. PubMed ID: 7919590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and etiology of chronic rejection of the heart.
    Billingham ME
    Clin Transplant; 1994 Jun; 8(3 Pt 2):289-92. PubMed ID: 8061370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model.
    Kobayashi J; Crawford SE; Backer CL; Zales VR; Takami H; Hsueh C; Huang L; Mavroudis C
    Circulation; 1993 Nov; 88(5 Pt 2):II286-90. PubMed ID: 8222167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can the progression of coronary heart disease be modified by calcium antagonists?].
    Schneider W; Roebruck P; Kober G; Alle M; Cieslinski G; Mildenberger D; Satter P; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():112-20. PubMed ID: 2698562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graft vascular disease. Its pathogenesis and diagnosis].
    Muñoz Aguilera R; García Robles JA; Palomo Alvarez J; Botas Rodríguez J
    Rev Esp Cardiol; 1995; 48 Suppl 7():115-28. PubMed ID: 8775826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of coronary artery pathologic findings in human cardiac allografts.
    Johnson DE; Gao SZ; Schroeder JS; DeCampli WM; Billingham ME
    J Heart Transplant; 1989; 8(5):349-59. PubMed ID: 2795279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery disease in patients with hearts from older donors: morphologic features and therapeutic implications.
    Schüler S; Matschke K; Loebe M; Hummel M; Fleck E; Hetzer R
    J Heart Lung Transplant; 1993; 12(1 Pt 1):100-8; discussion 108-9. PubMed ID: 8443187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac allograft vasculopathy: pathology, prevention and treatment.
    Kass M; Haddad H
    Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease.
    Eich D; Thompson JA; Ko DJ; Hastillo A; Lower R; Katz S; Katz M; Hess ML
    J Heart Lung Transplant; 1991; 10(1 Pt 1):45-9. PubMed ID: 2007170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.